retatrutide clinical trial retatrutide Phase III study demonstrates 30% weight loss How to Take Retatrutide Injection

No specific antidote is available for the treatment of Glutathione overdosage

Ozempic contains semaglutide GLP-1, a GLP-1 receptor agonist that works by increasing feelings of fullness, reducing appetite, and slowing stomach emptying

Excessive use may lead to kidney or liver strain

Retatrutide has not been approved by Health Canada and is not available through Canadian pharmacies or prescriptions

During the mean observation period of 3.3 years, semaglutide at 2.4 mg per week resulted in a mean weight loss of 9.39% from baseline and a 20% reduction in the risk of MACE (HR 0.80, 95% CI 0.720.90), especially a 28% reduction in the risk of myocardial infarction (HR 0.72, 95% CI 0.610.85), compared with that in the placebo group